albumin binding raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-25 and is reviewed periodically as new material appears.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Acylated GLP-1 receptor agonist | 31-residue synthetic peptide |
| Molecular formula | C187H291N45O59 | established for the free peptide |
| Appearance | White to off-white powder | as supplied before formulation |
| Solubility | Freely soluble in water | aqueous buffers near neutral pH |
| Typical storage | 2 to 8 degrees Celsius, protected from light | powder and solution forms differ in shelf life |
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
=== Theories on amputation === In medieval Europe, amputation was done on limbs as a last resort when the limb could not be saved. For limbs that were dead or decaying, surgeons categorized them into two main categories: hot fire and cold fire. Hot fire (also called Gangraena) was the first stage of a decaying limb. A body part with hot fire was hot, swollen, and painful. If not treated, the limb would turn cold. Cold fire (also called Sphacelus) was the late stage of limb death, including death of the bone. Symptoms included loss of feeling, coldness, and black and blue coloring. With time, the fire would spread and eventually kill the patient. Followers of Galen considered hot and cold fire to be based on the humors and an imbalance of hot, wet, dry, and cold in the body. Followers of Paracelsus believed that hot and cold fire were a result of Mercury, sulfur, and salt. While different surgeons drew from different medical theories of the time, they also used their own experiences to determine the root cause of the fires. There was often debate on whether a particular patient had cold or hot fire, which led to disagreements on treatment methods. Treatment for hot fire often included burning or cutting out damaged flesh. If the symptoms were mild enough, the skin could sometimes be regrown. Treatment for cold fire included removing the dead flesh and likely amputation.
=== Security and authentication === Security packaging can include tamper-evident closures, security printing, holograms, digital watermarks, RFID tags, unique serial numbers, covert markers, and forensic authentication features. These systems help identify counterfeiting, diversion, unauthorised opening, product substitution, and manipulation of the package. Authentication systems may combine visible, covert, forensic, and digital elements. Scan data from serialised codes can also help identify unusual copying or distribution patterns.
Zero – the Olmec independently invented the concept of zero. The second earliest found instance of the use of zero—in Mesoamerica—has been dated to 32 BCE by the Epi-Olmec culture. This date has been arrived at based on the Long Count date on Stela C at Tres Zapotes. The symbol used for "zero" is a shell glyph, which is seen on the stone carving. Although the Olmec didn't leave behind any statues or reliefs with a "zero" glyph, the use of the Long Count calendar requires the knowledge of this concept since it is based on a (vigesimal) place-value number system.
=== P187s === One widespread single-nucleotide polymorphism of the NQO1 gene (NQO1*2), found homozygous in 4% to 20% of different populations, has found to be connected with different forms of cancer and a lowered efficiency of some chemotherapeutics like mitomycin C. This single nucleotide polymorphism leads to a proline serine exchange on position 187. NAD(P)H dehydrogenase [quinone] 1 P187S has been shown to have a lowered activity and stability. Crystallographic and nuclear magnetic resonance data show that the reason for this different behaviour is found in a flexible C-terminus of the protein leading to a destabilization of the whole protein. Recent pharmacological research suggests feasibility of genotype-directed redox chemotherapeutic intervention targeting NQO1*2 breast cancer. A comprehensive meta-analysis showed an association between overall cancer risk and P187S.
Sources: en.wikipedia.org
Zverev maintained his top 5 ranking throughout the year. However, he still did not deliver any high-calibre results at the major tournaments. He was upset at the Australian Open by reigning Next Gen Finals champion and No. 59 Chung Hyeon in five sets in the third round. Zverev stated that issues at majors were "definitely not physical" when asked if his problems were physical or mental, and also attribute this lack of success to the extra pressure he was putting on himself at these events. Zverev did not reach his first final of the year until early April at the Miami Masters. Despite taking the first set of the final, he finished runner-up to American John Isner, who had never previously won a Masters title. Zverev continued his Masters success into the clay-court season, reaching the semifinals at the Monte Carlo Masters, winning his third career Masters title at the Madrid Open, and making the final at the Rome Masters. In Madrid, he defeated Dominic Thiem in the final to become the only active player outside of the Big Four to have won three Masters titles. He came close to winning back-to-back Masters events, going up a break in the third set against Nadal at the Italian Open. However, Nadal was able to recover and win the final five games of the match after a rain delay. Zverev had also defended his title at the Bavarian International Tennis Championships in his only other French Open tune-up to help build up a 13 match win streak that lasted until the Italian Open final.
2-Oxoadipic acid, also known as α-ketoadipic acid, is an intermediate in the metabolism of lysine and tryptophan. The conjugate base and carboxylate is 2-oxoadipate or α-ketoadipate, which is the biochemically relevant form. Glutaric acid is naturally produced by chain extension of α-ketoglutarate to 2-oxoadipic acid.
Providing medical prescriptions for pharmaceutical heroin (diacetylmorphine) to heroin-dependent people has been employed in some countries to address problems associated with the illicit use of the drug, as potential benefits exist for the individual and broader society. Evidence has indicated that this form of treatment can greatly improve the health and social circumstances of participants, while also reducing costs incurred by criminalisation, incarceration and health interventions. In Switzerland, heroin assisted treatment is an established programme of the national health system. Several dozen centres exist throughout the country and heroin-dependent people can administer heroin in a controlled environment at these locations. The Swiss heroin maintenance programme is generally regarded as a successful and valuable component of the country's overall approach to minimising the harms caused by illicit drug use. In a 2008 national referendum, a majority of 68 per cent voted in favour of continuing the Swiss programme. The Netherlands has studied medically supervised heroin maintenance. A German study of long-term heroin addicts demonstrated that diamorphine was significantly more effective than methadone in keeping patients in treatment and in improving their health and social situation. Many participants were able to find employment, some even started a family after years of homelessness and delinquency.
Sources: en.wikipedia.org
Methyl jasmonate is volatile and can therefore activate systemic acquired resistance in neighbouring plants, preparing their defences for attack. These signalling events are analogous to the cytokine-mediated inflammatory immune response in animals. When the inflammatory response is activated in animals, MAPKs are activated which in turn activate phospholipases. Lipids in the membrane are converted to arachidonic acid and then to prostaglandins, which are analogs of jasmonic acid. Both pathways can be inhibited by suramin. Early experiments with radiolabelled systemin in tomato demonstrated that it is transported through the phloem sap in tomato plants and was therefore thought to be the systemic signal that activated systemic acquired resistance. This view was challenged by grafting experiments which showed that mutants deficient in jasmonic acid biosynthesis and perception were unable to activate systemic acquired resistance. It is now thought that jasmonic acid is the systemic signal and that systemin upregulates the pathways for jasmonic acid synthesis.
== Legacy and later life == Singh's structured administration is credited with slowing India's rate of deforestation between 1960 and 1980 by introducing professional oversight and improving legal frameworks against illegal logging. After retiring from the civil service in 1969, he served as a Professor Emeritus at the Forest Research Institute and College for a five-year term, and later as the Managing Director of the Newsprint Paper and Pulp Mills in Nepanagar, Madhya Pradesh. His contributions were commemorated during his birth centenary in 2010 with the release of a biographical book, Hari Singh: A Life Sketch, and the establishment of the Hari Singh Fellowship at the Indira Gandhi National Forest Academy to honour outstanding IFS probationers. Singh was married and had at least one son, Dr. Subir Hari Singh. He passed away in 2003 at the age of 93.
Micronutrients are essential chemicals required by organisms in small quantities to perform various biogeochemical processes and regulate physiological functions of cells and organs. By enabling these processes, micronutrients support the health of organisms throughout life. For humans, micronutrients typically take one of three forms: vitamins, trace elements, and dietary minerals. Human micronutrient requirements are in amounts generally less than 100 milligrams per day, whereas macronutrients are required in gram quantities daily. Deficiencies in micronutrient intake commonly result in malnutrition. In ecosystems, micronutrients most commonly take the form of trace elements such as iron, strontium, and manganese. Micronutrient abundance in the environment greatly influences biogeochemical cycles at the microbial level which large ecological communities rely on to survive. For example, marine primary producers (also known as phytoplankton) are reliant upon bioavailable dissolved iron for photosynthesis. Secondary and tertiary producers in oceans are therefore also reliant on the presence of sufficient dissolved iron concentrations. Naturally, micronutrients are transferred between reservoirs through processes like fluvial transport, aeolian processes, ocean circulation, volcanism, and biological uptake/transfer. Anthropogenic activities also alter the abundance of micronutrients in ecosystems.
To the end of his life, Adorno never abandoned the hope of completing Berg's unfinished opera Lulu. At this time, Adorno was in intense correspondence with Walter Benjamin about the latter's Arcades Project. After receiving an invitation from Horkheimer to visit the Institute in New York, Adorno sailed for New York on 9 June 1937 and stayed for two weeks. While he was in New York, Horkheimer's essays "The Latest Attack on Metaphysics" and "Traditional and Critical Theory," which would soon become instructive for the institute's self-understanding, were the subject of intense discussion. Soon after his return to Europe, Gretel moved to Britain, where she and Adorno were married on 8 September 1937. A little over a month later, Horkheimer telegrammed from New York with news of a position Adorno could take with the Princeton Radio Project, then under the directorship of the Austrian sociologist Paul Lazarsfeld. Yet Adorno's work continued with studies of Beethoven and Richard Wagner (published in 1939 as "Fragments on Wagner"), drafts of which he read to Benjamin during their final meeting, in December on the Italian Riviera. According to Benjamin, these drafts were astonishing for "the precision of their materialist deciphering" as well as the way in which "musical facts ... had been made socially transparent in a way that was completely new to me." In his Wagner study, the thesis later to characterize Dialectic of Enlightenment—man's domination of nature—first emerges. Adorno sailed for New York on 16 February 1938.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.
The fatty diacid chain associates strongly with serum albumin, which keeps the peptide in circulation and shields it from rapid renal clearance. Bound peptide is released gradually, producing a sustained receptor signal. This mechanism also reduces the peak-to-trough variation seen with shorter-acting analogues.
The balance between peripheral receptor activation and signalling in the central nervous system is not fully resolved. The extent to which slowed gastric emptying accounts for reduced energy intake, compared with direct effects on appetite circuits, is debated. Long-term effects on lean mass and on tissues outside the gut and brain are still under study.
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.